Contemporary Concise Review 2022: Interstitial lung disease

OF KEY POINTSNovel genetic associations for idiopathic pulmonary fibrosis (IPF) risk have been identified. Common genetic variants associated with IPF are also associated with chronic hypersensitivity pneumonitis.The characterization of underlying mechanisms, such as pathways involved in myofibroblast differentiation, may reveal targets for future treatments.Newly identified circulating biomarkers are associated with disease progression and mortality.Deep learning and machine learning may increase accuracy in the interpretation of CT scans.Novel treatments have shown benefit in phase 2 clinical trials.Hospitalization with COVID-19 is associated with residual lung abnormalities in a substantial number of patients.Inequalities exist in delivering and accessing interstitial lung disease specialist care.